Immunotherapy Administration: Oncology Nursing Society Recommendations

Kathleen Wiley, RN, MSN, AOCNS®; Kristine B. LeFebvre, MSN, RN, AOCN®; Lisa Wall, PhD, RN; Abigail Baldwin-Medsker, MSN, RN, OCN®; Kim Nguyen, MT(ASCP), CIC; Lisa Marsh, BSN, MA, RN, CCRP; and Diane Baniewicz, MSN, CRNP
CJON
10.1188/17.CJON.s2.5-7

Description

As the use of immunotherapeutic agents increases in single-agent and multimodality treatment regimens, oncology nurses face the challenge of administering and caring for patients receiving new and unique agents. Oncology Nursing Society clinical staff and clinical nurses collaborated to produce a set of recommendations to educate nurses involved with the monitoring of patients receiving immunotherapy on administration procedures and safe handling of these agents to ensure patient and staff safety and to reduce risk of error. The recommendations are meant to provide clinical nurses with a framework on which to build policies and procedures for administering new treatment modalities.

 

 

 

View Article @ cjon.ons.org

ONS Voice Articles

ONS's member magazine articles.

View All Voice Articles